Literature DB >> 17692490

Assessment of extravascular extracellular space fraction in human melanoma xenografts by DCE-MRI and kinetic modeling.

Ilana C Benjaminsen1, Kjetil G Brurberg, Else-Beate M Ruud, Einar K Rofstad.   

Abstract

Tumor aggressiveness and response to therapy are influenced by the extravascular extracellular space fraction (EESF) of the malignant tissue. The EESF may, therefore, be an important prognostic parameter for cancer patients. The aim of this study was to investigate whether gadopentetate dimeglumine (Gd-DTPA)-based dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) can be used to assess the EESF of tumors. Amelanotic human melanoma xenografts (A-07, R-18) were used as preclinical models of human cancer. Images of E.F (E is the initial extraction fraction of Gd-DTPA and F is perfusion) and lambda (the partition coefficient of Gd-DTPA) were obtained by Kety analysis of DCE-MRI data. Our study was based on the hypothesis that lambda is governed by the EESF and is not influenced significantly by microvascular density (MVD) or blood perfusion. To test this hypothesis, we searched for correlations between lambda and E.F, MVD or EESF by comparing lambda images with E.F images, histological preparations from the imaged tissue and the radial heterogeneity in EESF obtained by invasive imaging. Positive correlations were found between lambda and EESF. Thus, median lambda was larger in A-07 tumors than in R-18 tumors by a factor of 4.2 (P<.00001), consistent with the histological observation that EESF is approximately fourfold larger in A-07 tumors than in R-18 tumors. The radial heterogeneity in lambda in A-07 and R-18 tumors was almost identical to the radial heterogeneity in EESF. Moreover, lambda was larger in tissue regions with high EESF than in tissue regions with low EESF in A-07 tumors (P=.048). On the other hand, significant correlations between lambda and MVD or E.F could not be detected. Consequently, Kety analysis of Gd-DTPA-based DCE-MRI series of xenografted tumors provides lambda images that primarily reflect the EESF of the tissue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17692490     DOI: 10.1016/j.mri.2007.06.003

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  15 in total

1.  A clinically feasible method to estimate pharmacokinetic parameters in breast cancer.

Authors:  Jun Li; Yanming Yu; Yibao Zhang; Shanglian Bao; Chunxue Wu; Xiaoying Wang; Jie Li; Xiaopeng Zhang; Jiani Hu
Journal:  Med Phys       Date:  2009-08       Impact factor: 4.071

Review 2.  Review of treatment assessment using DCE-MRI in breast cancer radiation therapy.

Authors:  Chun-Hao Wang; Fang-Fang Yin; Janet Horton; Zheng Chang
Journal:  World J Methodol       Date:  2014-06-26

3.  Extracellular volume fraction determined by equilibrium contrast-enhanced multidetector computed tomography as a prognostic factor in unresectable pancreatic adenocarcinoma treated with chemotherapy.

Authors:  Yoshihiko Fukukura; Yuichi Kumagae; Ryutaro Higashi; Hiroto Hakamada; Koji Takumi; Kosei Maemura; Michiyo Higashi; Kiyohisa Kamimura; Masanori Nakajo; Takashi Yoshiura
Journal:  Eur Radiol       Date:  2018-06-19       Impact factor: 5.315

4.  Extracellular volume fraction determined by equilibrium contrast-enhanced dual-energy CT as a prognostic factor in patients with stage IV pancreatic ductal adenocarcinoma.

Authors:  Yoshihiko Fukukura; Yuichi Kumagae; Ryutaro Higashi; Hiroto Hakamada; Masatoyo Nakajo; Kosei Maemura; Shiho Arima; Takashi Yoshiura
Journal:  Eur Radiol       Date:  2019-11-14       Impact factor: 5.315

5.  Rectal cancer: 3D dynamic contrast-enhanced MRI; correlation with microvascular density and clinicopathological features.

Authors:  W W Yao; H Zhang; B Ding; T Fu; H Jia; L Pang; L Song; W Xu; Q Song; K Chen; Z Pan
Journal:  Radiol Med       Date:  2011-02-01       Impact factor: 3.469

6.  Measurement of Tissue interstitial volume in healthy patients and those with amyloidosis with equilibrium contrast-enhanced MR imaging.

Authors:  Steve Bandula; Sanjay M Banypersad; Daniel Sado; Andrew S Flett; Shonit Punwani; Stuart A Taylor; Philip N Hawkins; James C Moon
Journal:  Radiology       Date:  2013-05-14       Impact factor: 11.105

7.  Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging in patients with rectal cancer: correlation with microvascular density and vascular endothelial growth factor expression.

Authors:  Yeo-Eun Kim; Joon Seok Lim; Junjeong Choi; Daehong Kim; Sungmin Myoung; Myeong-Jin Kim; Ki Whang Kim
Journal:  Korean J Radiol       Date:  2013-11-05       Impact factor: 3.500

Review 8.  Eco-evolutionary causes and consequences of temporal changes in intratumoural blood flow.

Authors:  Robert J Gillies; Joel S Brown; Alexander R A Anderson; Robert A Gatenby
Journal:  Nat Rev Cancer       Date:  2018-09       Impact factor: 60.716

9.  Tumor vascularity assessed by magnetic resonance imaging and intravital microscopy imaging.

Authors:  Jon-Vidar Gaustad; Kjetil G Brurberg; Trude G Simonsen; Camilla S Mollatt; Einar K Rofstad
Journal:  Neoplasia       Date:  2008-04       Impact factor: 5.715

Review 10.  Quantifying tumor vascular heterogeneity with dynamic contrast-enhanced magnetic resonance imaging: a review.

Authors:  Xiangyu Yang; Michael V Knopp
Journal:  J Biomed Biotechnol       Date:  2011-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.